Vedolizumab for Immune Mediated Colitis

Clinical trial NCT04797325 · UNKNOWN

Trial details

NCT number: NCT04797325
Sponsor: University of Copenhagen
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Immune-Mediated Colitis

Start date: 2021-08-30
Primary completion: 2025-04-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.